Invention Grant
- Patent Title: Dermatitis treatment
-
Application No.: US16117148Application Date: 2018-08-30
-
Publication No.: US10758499B2Publication Date: 2020-09-01
- Inventor: Berit Johansen
- Applicant: Avexxin AS
- Applicant Address: NO Trondheim
- Assignee: Avexxin AS
- Current Assignee: Avexxin AS
- Current Assignee Address: NO Trondheim
- Agency: McCarter & English, LLP
- Agent Steven G. Davis
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@65195609
- Main IPC: A61K31/121
- IPC: A61K31/121

Abstract:
A compound of formula (I) R-L-CO—X (I) (wherein R is a C10-24 unsaturated hydrocarbon group optionally interrupted by one or more heteroatoms or groups of heteroatoms selected from S, O, N, SO, SO2, said hydrocarbon group comprising at least 4 non-conjugated double bonds; L is a linking group forming a bridge of 1 to 5 atoms between the R group and the carbonyl CO wherein L comprises at least one heteroatom in the backbone of the linking group; and X is an electron withdrawing group) or a salt thereof for use in the treatment of dermatitis.
Public/Granted literature
- US20190167606A1 DERMATITIS TREATMENT Public/Granted day:2019-06-06
Information query